Upstate Active Clinical Trials
Study Title:A Phase I-II, Randomized, Double-Blind, Study to Evaluate the Safety, Tolerability, and Immunogenicity of Different Formulations of V114 in Healthy Adults and Infants
What is the purpose of the study? (in Layman's terms, please describe the study)The purpose of this study is to:
• Test the safety and tolerability of 4 different formulations of the research study vaccine, V114.
• Test the immune system response to the study vaccine, V114.
Upstate Institutional Review Board (IRB) Number:784386
Study Phase:Phase I-II
Patient Age Group:Children
Principal Investigator:Leonard B Weiner
Who can I contact for more information?
Name: Kristen Fluno